{"name":"Senhwa Biosciences, Inc.","slug":"senhwa-biosciences-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxORkxHUUhJeFlWeDl4MUZxMG1NU1d2dEJQaEhDZXhjYTZDUkI3Z2dIcTVPZEtDRXI2UnY5MnIxWUQ4OU5SNXBuc1ZHNDFhRk15NjQ5b3RqR3BqTl9RVzQ4Qk1Yc0RiY29pS3pkQkw5MS1VanB6NDhMYUFBZi1nWS1VSTFsMnNUVkhOUWpqSDF5TE4xSzlocTJWdEVXaTVNWGtZd0FQMlZKVUgyRFhwOG5vNFRUZHZMdG9kLTlXM1hHV3AtX21tRk16ZkhhckdnOVUtMW1FNklkY2k?oc=5","date":"2026-04-01","type":"pipeline","source":"Barchart.com","summary":"COVID-19 Treatment Pipeline Shows Strong Momentum as 180+ Pharma Companies in the Race | DelveInsight - Barchart.com","headline":"COVID-19 Treatment Pipeline Shows Strong Momentum as 180+ Pharma Companies in the Race | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-18","type":"pipeline","source":"The Manila Times","summary":"Breakthrough at 2026 AACR! Senhwa Biosciences' CX-5461 Enters the Field of Photodynamic Therapy, Opening a New Indication Strategy - The Manila Times","headline":"Breakthrough at 2026 AACR! Senhwa Biosciences' CX-5461 Enters the Field of Photodynamic Therapy, Opening a New Indicatio","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-03","type":"pipeline","source":"PR Newswire","summary":"Senhwa Biosciences Signs Major Strategic MOU with Y Combinator-Backed AI Biotech Company CellType to Accelerate the Evolution of CX-4945 into Version 2.0 and Reshape the Global Immunotherapy Landscape","headline":"Senhwa Biosciences Signs Major Strategic MOU with Y Combinator-Backed AI Biotech Company CellType to Accelerate the Evol","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxQVlRkTll3MTFwUmw2M25SeXdYSkxRd2JSZnhSQXhJSzhBb09RblViLVlJR2ZzbHktZnpLaEpRdkdITVBJOExRVkptR19tVmFHZ2p0YVlSeXlLa2o2cGxvYUFnTGpqZkFodlM0SUVFN3hqMUlyUncwWW9CNWt6NElmRHZScUN4cnBrLUNoMk1OajZRNG1uSFRKVmlBbmJSOG9TeF83VmstWWthV0NVMlhoUXpDbC1KeVBYMXgzeGJCd01Nb0xTVHJvQVVOZGxSY2xSMUozQnlBdTcxNHIxVGl4S2FLdzA5b3daM20zcmEyb1czVjhtbW1QOGVKY1QydEdBSzVDOFhYLVlQTkFMdUNyWFI0cmhSYmVOYkljNGZR?oc=5","date":"2026-03-02","type":"regulatory","source":"PR Newswire","summary":"Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight - PR Newswire","headline":"Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (202","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxPakNGTXY0cUwxUFZ0UUFQdHhxVWtlSmVfcFVydFBMckhKdzc5NXhQNDJMUXFDSTg2aXZkOUZHRExiZ21naGtNeXBacjdqdENWX05zUDNCQnpCTmsySGQwMUVmbmg2U3VOREstTzh5SFdsWUNEZzRqV1JQWVBfMjNSd3lIMU56dmpiYlNzeE96V09pTXZIQi1LZDJnQjZxVzZwN0plbGpOckNpem05bE9jcEZTbWZmMkpDZWY2WXhSOTViVlVSSnV3eDJDeVlXcF8yOVU0dDVJeHlGNTdvTG1pNnpxY3NHczZGWGRsRFZ1R19BZm93cU44LXptTkQ?oc=5","date":"2025-12-28","type":"pipeline","source":"PR Newswire","summary":"Senhwa Biosciences Aims at Multi-Billion Dollar Global Market with CX-5461 Combined with ADC \"Blockbuster\" Therapy - PR Newswire","headline":"Senhwa Biosciences Aims at Multi-Billion Dollar Global Market with CX-5461 Combined with ADC \"Blockbuster\" Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPekdqd0ZLQ3J3NXdXcHQ0NnFTR2ViQ0pyZEZaakVleWMtTVBhb0RuM1VCR2thT0pzb2xDZS1iQXpIWjg4S0tZVThMSmFCdndERG81VU1VMDVxZjMycmlSV1ZTTkV5bWhyY2JtZ2htSV9uNWpiX040SkFpWnFKN1RmWUtmT29qUFhJ?oc=5","date":"2025-09-10","type":"trial","source":"Yahoo Finance","summary":"Basal Cell Neoplasms Clinical Trial Pipeline Accelerates as 22+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Yahoo Finance","headline":"Basal Cell Neoplasms Clinical Trial Pipeline Accelerates as 22+ Pharma Companies Rigorously Develop Drugs for Market Ent","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTFBPdHhZU0NYUTBSN1huR2RFbE0tcVRaWWs0NHpyZm1DaGtYQTlZd3dHLW1NcVliVVlpWlF3UEtIM1lIUGF6REdWQzJNRzhFZW5QbWVQNnE4azY4WS1KbDJUbExFN3pmN3pPZEJzTTlnWmE?oc=5","date":"2025-03-05","type":"pipeline","source":"Labiotech.eu","summary":"The 7 hottest biotech companies in Taiwan - Labiotech.eu","headline":"The 7 hottest biotech companies in Taiwan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE1UZDF6N1NjY2FzcnA1THM3S2Y4X2xwVEYwSUlHQUJobjhyUXRmUXRKd2wzTmJTMDctZHhlUjZQMEVVMWdLUVlZaERPSkI0eWxaR2VQSVNlZ2dBZw?oc=5","date":"2021-09-25","type":"pipeline","source":"TradingView","summary":"6492 Stock Price and Chart — TPEX:6492 - TradingView","headline":"6492 Stock Price and Chart — TPEX:6492","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOZHNpWnlwMlJTYm1RMVVUeU5GdjAwY0k3d3FDMFh1eF95eFY5WXN0eWlrY0FXeWVHOUREWUMwajN5TjhiaWxHTnNPcFB3VHVqSlR3ZlB5VmMyVFRWdHM0OWpuR2w2M2daNVZfN2c3MU9RLWRCUlRYWnFCS2ZldERhR05NakZ6dm9iLWFQX3NIRFlvZ2liaUpQb1V3cDN6N1JmRzlJSUxFNGxKTVVUZ3VlbVZyVQ?oc=5","date":"2018-12-20","type":"pipeline","source":"The Conversation","summary":"Drug development is no longer just for Big Pharma. Researchers at Bio-X explain - The Conversation","headline":"Drug development is no longer just for Big Pharma. Researchers at Bio-X explain","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}